CurrentCardio coverage · page 9 of 15

European Journal of Heart Failure

Briefs 321–360 of 588 CurrentCardio has covered from this journal, newest publication first

Latest from European Journal of Heart Failure

All coverage, newest first

Eur J Heart Fail12 Dec 2024
End-organ Protective Effect of Serelaxin in Patients Hospitalized for Heart Failure: Results of the Biomarker Substudy of Relaxin in Acute Heart Failure-2 (RELAX-AHF-2)
Secondary analysisHeart failure
Eur J Heart Fail11 Dec 2024
Management of Acute Decompensated Valvular Heart Disease
Meta-analysisValvular & structural
Eur J Heart Fail10 Dec 2024
Machine Learning Approach to Identify Phenotypes in Patients with Ischaemic Heart Failure with Reduced Ejection Fraction
Secondary analysisHeart failure
Eur J Heart Fail9 Dec 2024
Long-Term Rate of Heart Failure in Patients with Autoimmune Disease: A Nationwide Cohort Study
Cohort studyHeart failure
Eur J Heart Fail5 Dec 2024
Endomyocardial Biopsy in the Diagnosis of Cardiac Sarcoidosis
Cohort studyHeart failure
Eur J Heart Fail5 Dec 2024
Outpatient Worsening of Heart Failure and Mortality in Transthyretin Amyloid Cardiomyopathy
Cohort studyHeart failure
Eur J Heart Fail5 Dec 2024
The Global Burden of Disease Attributable to High Body Mass Index in 204 Countries and Territories from 1990 to 2021 with Projections to 2050: An Analysis of the Global Burden of Disease Study 2021
Research articleCardiometabolic & kidney
Eur J Heart Fail2 Dec 2024
The Prognostic Value of the Dandel's Index in Patients Undergoing Tricuspid Transcatheter Edge-to-Edge Repair
Cohort studyValvular & structural
Eur J Heart Fail2 Dec 2024
Diuretic Efficiency of a Single Dose of Subcutaneous Versus Oral Furosemide After Heart Failure Hospitalization Across Diuretic Resistance Strata: A Pilot Randomized Controlled Trial
Randomised controlled trialHeart failure
Eur J Heart Fail1 Dec 2024
Midterm Outcomes of Patients with Native Heart Recovery After Impella 5+ for Cardiogenic Shock
Cohort studyAcute care & resuscitation
Eur J Heart Fail28 Nov 2024
Associations of Iron Deficiency with Cardiac Function, Congestion, Exercise Capacity and Prognosis in Heart Failure
Cohort studyHeart failure
Eur J Heart Fail26 Nov 2024
Mesenchymal Precursor Cells Reduce Mortality and Major Morbidity in Ischaemic Heart Failure with Inflammation: DREAM-HF
Secondary analysisHeart failure
Eur J Heart Fail26 Nov 2024
Relevance of Residual Tricuspid Regurgitation for Right Ventricular Reverse Remodelling After Tricuspid Valve Intervention in Patients with Severe Tricuspid Regurgitation and Right-Sided Heart Failure
Cohort studyValvular & structural
Eur J Heart Fail26 Nov 2024
Discontinuation and Reinitiation of Mineralocorticoid Receptor Antagonists in Patients with Heart Failure and Reduced Ejection Fraction
Cohort studyHeart failure
Eur J Heart Fail26 Nov 2024
New Cardiovascular Biomarkers in Patients with Advanced Cancer – A Prospective Study Comparing MR-proADM, MR-proANP, Copeptin, High-Sensitivity Troponin T and NT-proBNP
Cohort studyCardio-oncology & other
Eur J Heart Fail22 Nov 2024
State of the Art and Perspectives of Gene Therapy in Heart Failure. A Scientific Statement of the Heart Failure Association of the ESC, the ESC Council on Cardiovascular Genomics and the ESC Working Group on Myocardial & Pericardial Diseases
Guideline or statementHeart failure
Eur J Heart Fail19 Nov 2024
Effects of Sacubitril/Valsartan According to Background Beta-Blocker Therapy in Patients with Heart Failure and Reduced Ejection Fraction: Insights from PARADIGM-HF
Secondary analysisHeart failure
Eur J Heart Fail19 Nov 2024
Knowledge and Application of ESC/HFA Guidelines in the Management of Advanced Heart Failure
Cross-sectional studyHeart failure
Eur J Heart Fail12 Nov 2024
Long-Term Risk of Heart Failure in Patients with Postoperative Atrial Fibrillation Following Non-Cardiac Surgery: Insights from a Nationwide Cohort
Cohort studyArrhythmias & EP
Eur J Heart Fail11 Nov 2024
Preventive Catheter Ablation for Ventricular Arrhythmias in Patients with End-Stage Heart Failure Referred for Heart Transplantation Evaluation: Rationale for and Design of the CASTLE-VT Trial
Trial designHeart failure
Eur J Heart Fail5 Nov 2024
Long-Term Clinical Outcomes and Healthcare Resource Utilization in Male and Female Patients Following Hospitalization for Heart Failure
Secondary analysisHeart failure
Eur J Heart Fail30 Oct 2024
Vericiguat Global Study in Participants with Chronic Heart Failure: Design of the VICTOR Trial
Trial designHeart failure
Eur J Heart Fail28 Oct 2024
Trends in Heart Failure Mortality in Sweden Between 1997 and 2022
Cohort studyHeart failure
Eur J Heart Fail24 Oct 2024
Effects of Atrial Fibrillation Ablation on Arrhythmia Burden and Ventricular Function in End-Stage Heart Failure: Lessons from CASTLE-HTx
Secondary analysisArrhythmias & EP
Eur J Heart Fail24 Oct 2024
Timing of Veno-Arterial Extracorporeal Membrane Oxygenation Support in Patients with Cardiogenic Shock
Cohort studyAcute care & resuscitation
Eur J Heart Fail22 Oct 2024
Long-Term Exposure to Fine Particulate Matter Constituents, Genetic Susceptibility, and Incident Heart Failure Among 411 807 Adults
Cohort studyHeart failure
Eur J Heart Fail22 Oct 2024
The Global, Regional, and National Burden of Myocarditis in 204 Countries and Territories, 1990–2021: Results From the Global Burden of Disease Study 2021
Research articleHeart failure
Eur J Heart Fail22 Oct 2024
Visit-to-Visit Changes in Heart Rate in Heart Failure: A Pooled Participant-Level Analysis of the PARADIGM-HF and PARAGON-HF Trials
Meta-analysisHeart failure
Eur J Heart Fail9 Oct 2024
Cardiovascular Outcomes with Exenatide in Type 2 Diabetes According to Ejection Fraction: The EXSCEL Trial
Secondary analysisCardiometabolic & kidney
Eur J Heart Fail4 Oct 2024
Diuretic Dosing and Outcomes with Torsemide and Furosemide Following Hospitalization for Heart Failure: The TRANSFORM-HF Trial
Secondary analysisHeart failure
Eur J Heart Fail2 Oct 2024
Multicentre, Randomized, Double-Blind, Prospective Study on the Effects of ImmunoAdSorptiOn on Cardiac Function in Patients with Dilated CardioMyopathy (IASO-DCM): Rationale and Design
Trial designHeart failure
Eur J Heart Fail2 Oct 2024
Revascularization and Outcomes in Ischaemic Left Ventricular Dysfunction After Heart Failure Admission: The RevascHeart Study
Cohort studyHeart failure
Eur J Heart Fail30 Sep 2024
Long-Term Follow-Up of the TRED-HF Trial: Implications for Therapy in Patients with Dilated Cardiomyopathy and Heart Failure Remission
Secondary analysisHeart failure
Eur J Heart Fail26 Sep 2024
Mechanisms behind the high mortality rate in chronic Chagas cardiomyopathy: Unmasking a three‐headed monster
Research articleHeart failure
Eur J Heart Fail24 Sep 2024
Cardio-Ocular Syndrome: Retinal Microvascular Changes in Acutely Decompensated Heart Failure
Cohort studyHeart failure
Eur J Heart Fail24 Sep 2024
Effect of Seasonal Influenza and COVID-19 Vaccination on Severity and Long-Term Outcomes of Patients with Heart Failure Decompensations
Cohort studyHeart failure
Eur J Heart Fail19 Sep 2024
In‐hospital course of patients with heart failure with improved ejection fraction in the DELIVER trial
Secondary analysisHeart failure
Eur J Heart Fail19 Sep 2024
Predicting Survival After Impella Implantation in Patients with Cardiogenic Shock: The J-PVAD Risk Score
Diagnostic or prognostic study
Eur J Heart Fail12 Sep 2024
Timing of Sodium–Glucose Cotransporter 2 Inhibitor Initiation and Post-Discharge Outcomes in Acute Heart Failure with Diabetes: A Population-Based Cohort Study
Cohort studyHeart failure
Eur J Heart Fail10 Sep 2024
Heart failure in Europe: Guideline‐directed medical therapy use and decision making in chronic and acute, pre‐existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction – the ESC EORP Heart Failure III Registry
Cohort studyHeart failure

All 588 Briefs in ExploreShowing Briefs 321–360 of 588, newest first